196 related articles for article (PubMed ID: 25225751)
1. Design of PLGA based nanoparticles for imaging guided applications.
Mariano RN; Alberti D; Cutrin JC; Geninatti Crich S; Aime S
Mol Pharm; 2014 Nov; 11(11):4100-6. PubMed ID: 25225751
[TBL] [Abstract][Full Text] [Related]
2. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
3. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization and in vitro and in vivo investigation of C₃F₈-filled poly(lactic-co-glycolic acid) nanoparticles as an ultrasound contrast agent.
Wang CW; Yang SP; Hu H; Du J; Li FH
Mol Med Rep; 2015 Mar; 11(3):1885-90. PubMed ID: 25394467
[TBL] [Abstract][Full Text] [Related]
6. Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents.
Doiron AL; Homan KA; Emelianov S; Brannon-Peppas L
Pharm Res; 2009 Mar; 26(3):674-82. PubMed ID: 19034628
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging.
Ye F; Barrefelt A; Asem H; Abedi-Valugerdi M; El-Serafi I; Saghafian M; Abu-Salah K; Alrokayan S; Muhammed M; Hassan M
Biomaterials; 2014 Apr; 35(12):3885-94. PubMed ID: 24495486
[TBL] [Abstract][Full Text] [Related]
8. Nile Red Loaded PLGA Nanoparticles Surface Modified with Gd-DTPA for Potential Dual-Modal Imaging.
Li Q; Li C; Tong W
J Nanosci Nanotechnol; 2016 Jun; 16(6):5569-76. PubMed ID: 27427598
[TBL] [Abstract][Full Text] [Related]
9. A new magnetic resonance imaging contrast agent loaded into poly(lacide-co-glycolide) nanoparticles for long-term detection of tumors.
Rigaux G; Roullin VG; Cadiou C; Portefaix C; Van Gulick L; Bœuf G; Andry MC; Hoeffel C; Vander Elst L; Laurent S; Muller R; Molinari M; Chuburu F
Nanotechnology; 2014 Nov; 25(44):445103. PubMed ID: 25325295
[TBL] [Abstract][Full Text] [Related]
10. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P
Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540
[TBL] [Abstract][Full Text] [Related]
11. Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent.
Wheatley MA; Forsberg F; Oum K; Ro R; El-Sherif D
Ultrasonics; 2006 Nov; 44(4):360-7. PubMed ID: 16730047
[TBL] [Abstract][Full Text] [Related]
12. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
14. trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16-F10 cells: cytotoxicity and phototoxicity.
Gomes AJ; Espreafico EM; Tfouni E
Mol Pharm; 2013 Oct; 10(10):3544-54. PubMed ID: 23865934
[TBL] [Abstract][Full Text] [Related]
15. Improved double emulsion technology for fabricating autofluorescent microcapsules as novel ultrasonic/fluorescent dual-modality contrast agents.
Gong A; Ma X; Xiang L; Ren W; Shen Z; Wu A
Colloids Surf B Biointerfaces; 2014 Apr; 116():561-7. PubMed ID: 24583258
[TBL] [Abstract][Full Text] [Related]
16. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
Han R; Zhu J; Yang X; Xu H
J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162
[TBL] [Abstract][Full Text] [Related]
17. Design of hybrid multimodal poly(lactic-co-glycolic acid) polymer nanoparticles for neutrophil labeling, imaging and tracking.
Qiu Y; Palankar R; Echeverría M; Medvedev N; Moya SE; Delcea M
Nanoscale; 2013 Dec; 5(24):12624-32. PubMed ID: 24177321
[TBL] [Abstract][Full Text] [Related]
18. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
[TBL] [Abstract][Full Text] [Related]
19. Theranostic vesicles based on bovine serum albumin and poly(ethylene glycol)-block-poly(L-lactic-co-glycolic acid) for magnetic resonance imaging and anticancer drug delivery.
Liu Q; Zhu H; Qin J; Dong H; Du J
Biomacromolecules; 2014 May; 15(5):1586-92. PubMed ID: 24690007
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-conjugated poly(lactic-co-glycolic acid) nanoparticles for protein delivery to macrophages.
Lee SY; Cho HJ
J Colloid Interface Sci; 2017 Mar; 490():391-400. PubMed ID: 27914338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
